tirzepatide chronic kidney disease trial A Study of (LY3298176) in Participants With Overweight or Obesity and With or Without Type 2 Diabetes (TREASURE-CKD) A comparison of the effects

Ante Piljac for sharing this poster with the community and for raising awareness about this possible therapeutic avenue

Always increase dosages slowly and systematically based on tolerance

Patients should be informed about the increased risk of gallbladder disorders (cholelithiasis, cholecystitis) with GLP-1 receptor agonists and weight loss, and advised to seek medical attention for symptoms such as right upper quadrant pain, fever, or jaundice

Stimulation of insulin secretion by gastric inhibitory polypeptide in man

For rates of T1DM device use, patients in each cohort were categorized based on their usage of CGMs, insulin pumps, both CGMs and pumps, or neither device